[Clinical aspects of ovarian endodermal sinus tumor]

Area of Science:

• Gynecologic Oncology
• Medical Oncology
• Pathology

Context:

• Ovarian endodermal sinus tumors (ESTs) are rare but aggressive germ cell malignancies.
• Historically, treatment relied on surgery and radiation therapy, with limited success.
• This study retrospectively analyzes clinical data from 1970-1983.

Purpose:

• To evaluate the clinical characteristics and treatment outcomes of ovarian endodermal sinus tumors.
• To compare the efficacy of different therapeutic regimens, including radiation and chemotherapy.
• To identify challenges and areas for improvement in managing this rare ovarian cancer.

Summary:

• Retrospective analysis of 22 ovarian endodermal sinus tumor patients treated between 1970 and 1983.
• Pre-1977 radiation therapy yielded poor survival (2/13 survivors).
• Post-1978 multi-drug chemotherapy significantly improved prognosis (6/8 survived, 4 with no evidence of disease).
• Effective regimens included vincristine, actinomycin D, cyclophosphamide, or platinum-based combinations.
• Challenges included acquired drug resistance in 50% of cases and severe treatment side effects.
• Two patients discontinued treatment due to toxicity.

Impact:

• Multi-drug chemotherapy represents a significant advancement in treating ovarian endodermal sinus tumors.
• The study highlights the need for more effective and tolerable chemotherapy regimens.
• Further research is crucial to optimize treatment strategies for malignant germ cell tumors.